XTL BIOPHARMACEUTICALS LTD. Cost Of Sales
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Cost Of Sales of $448.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement
ifrs-full:CostOfSales · last filed 2025-04-30
| Period end | Cost Of Sales 12 month |
|---|---|
| 2024-12-31 | $448.00K 20-F · filed 2025-04-30 |